Groundbreaking: China's Filing Guidance and Conversion Approval Regulations under Order No. 818 Officially Released — Marking the Nation's First National-Level Guidelines for Phage Therapy
On April 30, 2026, the much-anticipated Filing Guidance and Operational Specifications for Transformation Approval of Biomedical New Technologies under Order No. 818 were officially released, providing clear filing details and transformation approval requirements for 14 biomedical new technologies, including phage therapy. For phage therapy, this marks the first national-level guiding document in the field.